# COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT SALMONELLA TYPHI IN TERMS OF TIME TO DEFERVESCENCE

> **NCT07641348** · NA · NOT_YET_RECRUITING · sponsor: **Iqra Asghar Ali** · enrollment: 94 (estimated)

## Conditions studied

- Typhoid Fever

## Interventions

- **DRUG:** meropenem
- **DRUG:** Meropenem and azithromycin combination

## Key facts

- **NCT ID:** NCT07641348
- **Lead sponsor:** Iqra Asghar Ali
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2027-01-01
- **Final completion:** 2027-02-01
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641348, "COMPARISON OF SINGLE VERSUS COMBINATION DRUG THERAPY IN EXTENSIVELY DRUG RESISTANT SALMONELLA TYPHI IN TERMS OF TIME TO DEFERVESCENCE". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*